AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2023 Earnings Call Transcript August 3, 2023
AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $0.13.
Operator: Good afternoon, and thank you, and welcome to AbCellera’s Second Quarter 2023 Business Update Conference Call. My name is Jason, and I will be the facilitator for the audio portion of today’s interactive broadcast. All lines will be muted during the presentation portion of the call with...
